Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2020 Earnings Conference Call May 6, 2020 11:30 AM ET
Company Participants
Wade Walke - VP, IR
Brett Monia - CEO
Beth Hougen - CFO
Richard Geary - EVP, Development
Onaiza Cadoret - Chief Corporate Development and Commercial Officer
Eric Swayze - EVP, Research
Conference Call Participants
Jim Birchenough - Wells Fargo
Tyler Van Buren - Piper Sandler
Chad Messer - Needham and Company
Esther Rajavelu - Oppenheimer
Eliana Merle - Cantor Fitzgerald
Yale Jen - Laidlaw and Company
Jessica Fye - J.P. Morgan
Ritu Baral - Cowen
Josh Schimmer - Evercore ISI
Operator
Good morning and welcome to the Ionis Pharmaceuticals First Quarter 2020 Financial Results Conference Call. [Operator Instructions]. At this time I would like to turn the call over to Wade Walke Vice President Investor Relations to lead off the call. Please begin.
Wade Walke
Thank you Allyssa. Before we begin I encourage everyone to go to the Investors section of the Ionis website to find the press release and related financial tables including a reconciliation of the GAAP to non-GAAP financial measures that we will discuss today.
We believe non-GAAP financial results better represent the economics of our business and how we manage our business. We have also posted slides on our website to accompany our discussion today. With me on today's call are Brett Monia Chief Executive Officer; Beth Hougen Chief Financial Officer; and Richard Geary, Executive Vice President of Development.
Additional Onaiza Cadoret, Chief Corporate Development and Commercial Officer and Eric Swayze, Executive Vice President of Research will join us for Q&A. I would like to draw your attention to slide three which contains our forward-looking language statement.
We'll be making forward-looking statements which are based on our current expectations and beliefs. These statements are subject to certain risks and
- Read more current IONS analysis and news
- View all earnings call transcripts